Opportunities and Challenges in Pharmaceutical Sciences. Helen Gordon Chief Executive

Size: px
Start display at page:

Download "Opportunities and Challenges in Pharmaceutical Sciences. Helen Gordon Chief Executive"

Transcription

1 Opportunities and Challenges in Pharmaceutical Sciences Helen Gordon Chief Executive

2 Challenges we face

3 Drivers for Change in Health Care... and science too Desire for high quality, safe services. The need for cost effectiveness not just efficiencies The need for fast adoption and diffusion of innovation Changing demography, long term conditions time bomb Complexity of therapy New technologies The need for a flexible and adaptable workforce Balancing national and local Focus on outcomes

4 Cross Sector Change Working in Partnership Challenges Innovations Efficiencies Effectiveness

5 Changes in Workforce Development LETBs Health Education England Levy and Tariff

6 All about adopting and spreading innovation Science, health and education working closely together Pharmaceutical science is core Growing the economy through innovation

7 Quality Innovation Education and Development Effectiveness Delivery

8 Pharmaceutical Science - meeting the challenges - making the most of opportunities

9 Pharmaceutical Science - Crucial to Patient Care Formulations Solubility Patency of veins, running more than 1 drug into a line at the same time Managed entry of new drugs Palatability and formulations

10 Directions of Travel in Healthcare Do elements of this this resonate with you as well? Clinical Leadership and ownership that delivers: Quality improvement Best outcomes for patients Best use of resources Planning and designing integrated care pathways Strategies for service planning, research and health improvement Leadership and engagement Working collaboratively across systems Patient/User involvement, not just engagement

11 Royal Colleges Role - Support and Influence Professional Support. Professional Development & Advancement Leadership and advocacy Science and Research Professional Recognition Professional Standards

12 RPS working for Pharmacists and Pharmaceutical Scientists We work with our partners, such as APS, to ensure: SCIENCE is heard and understood, championed and valued Our partner s voices are heard and promoted in the development and delivery of healthcare policy and medicines expertise Their contribution to patient and public health is recognised and acknowledged They are positioned and trusted as the experts in medicines They are recognised as valued partners with the NHS, the science community, UKPLC and wider society. RPS recognition scheme coming soon.

13 High Media Presence

14 In Summary RPS and APS collaborate to: Ensure that pharmaceutical science is recognised as integral to patient care and wellbeing of the public. Spell out where pharmacy and pharmaceutical science add value, and how the professional bodies aid in this process. Create space for leaders to consider innovation and its spread. Ensure pharmaceutical science is embedded in educational change for pharmacists. Support changes to develop flexible and adaptable workforces in industry, healthcare, academia and research. As individuals, we: Make local connections that support advancement and change. Build partnerships at a national and local level will help patient care and business. Be passionate about developments and opportunities.

15 Thank you

16 RPS Science Award Presented by Helen Gordon Chief Executive

17 RPS Science Award Dr Khuloud Al-Jamal, King s College London

Innovation & health connected. Business plan summary

Innovation & health connected. Business plan summary Innovation & health connected Business plan summary 2017-18 CONTENTS Contents Introduction What do we do? Our five goals Goal 1: Transformation through innovation Goal 2: Economic growth Goal 3: Adoption

More information

Empowering young people. headspace Strategic Plan

Empowering young people. headspace Strategic Plan Empowering young people 1. headspace Strategic Plan 2010-2012 Vision To improve the mental and social wellbeing of young Australians through the provision of high quality early intervention services, that

More information

NHS SOUTH NORFOLK CLINICAL COMMISSIONING GROUP COMMUNICATIONS AND ENGAGEMENT STRATEGY

NHS SOUTH NORFOLK CLINICAL COMMISSIONING GROUP COMMUNICATIONS AND ENGAGEMENT STRATEGY NHS SOUTH NORFOLK CLINICAL COMMISSIONING GROUP COMMUNICATIONS AND ENGAGEMENT STRATEGY 2014-16 Ref Number: Version 3.0 Status FINAL DRAFT Author Oliver Cruickshank Approval body Governing Body Date Approved

More information

Helping your business grow in the UK health system

Helping your business grow in the UK health system Helping your business grow in the UK health system OVERVIEW PROVIDING INSIGHT AND HELPING YOU DELIVER INNOVATIVE PRODUCTS AND SERVICES TO THE NHS AND BEYOND. The health system is a complex and uncertain

More information

NHS Next Stage Review: Innovation

NHS Next Stage Review: Innovation NHS Next Stage Review: Innovation January 2008 Introduction 1. The Academy of Medical Sciences welcomes the opportunity to contribute to the NHS Next Stage Review. In this short response we have focused

More information

INNOVATION, HEALTH AND WEALTH ACCELERATING THE ADOPTION AND DIFFUSION IN THE NHS. MELANIE OGDEN DEPUTY DIRECTOR OF INNOVATION October 2013

INNOVATION, HEALTH AND WEALTH ACCELERATING THE ADOPTION AND DIFFUSION IN THE NHS. MELANIE OGDEN DEPUTY DIRECTOR OF INNOVATION October 2013 INNOVATION, HEALTH AND WEALTH ACCELERATING THE ADOPTION AND DIFFUSION IN THE NHS MELANIE OGDEN DEPUTY DIRECTOR OF INNOVATION October 2013 The Challenge Our ambition must be for an NHS defined by its commitment

More information

Digital Health. Jiban Khuntia, PhD. Assistant Professor Business School University of Colorado Denver

Digital Health. Jiban Khuntia, PhD. Assistant Professor Business School University of Colorado Denver Digital Health Jiban Khuntia, PhD Assistant Professor Business School University of Colorado Denver Digital Digital usually refers to something using digits, particularly binary digits. Examples: Digital

More information

Digital Health Strategy

Digital Health Strategy Digital Health Strategy i3 Digital Health Strategy Digital health requires a change in mindset Purpose Drive a change in mindset towards engagement online Goal Exceptional and safe online behaviour and

More information

Industrial Strategy Green Paper Response from The Institute of Cancer Research, London

Industrial Strategy Green Paper Response from The Institute of Cancer Research, London Industrial Strategy Green Paper Response from The Institute of Cancer Research, London March 2017 The Institute of Cancer Research (ICR) is one of the world s most influential cancer research organisations

More information

Cultural Evolution Is the future in our own hands?

Cultural Evolution Is the future in our own hands? Cultural Evolution Is the future in our own hands? Dr Paul Litchfield - Chief Medical Officer, BT Group Laura Collins - Carer and East Belfast ICP member Colette Goldrick - NI Director, APBI Dr Anne Kilgallen

More information

NIHR ROADSHOW FOR MEDTECH SMES

NIHR ROADSHOW FOR MEDTECH SMES MARTIN HUNT, DIRECTOR FOR INVENTION FOR INNOVATION (i4i) PROGRAMME, NATIONAL INSTITUTE FOR HEALTH RESEARCH Martin is Programme Director for i4i, a translational funding programme. i4i aims to support and

More information

ABHI Response to the Kennedy short study on Valuing Innovation

ABHI Response to the Kennedy short study on Valuing Innovation ABHI Response to the Kennedy short study on Valuing Innovation Introduction 1. The Association of British Healthcare Industries (ABHI) is the industry association for the UK medical technology sector.

More information

the royal society of new zealand: gateway to science and technology strategic priorities

the royal society of new zealand: gateway to science and technology strategic priorities the royal society of new zealand: gateway to science and technology strategic priorities www.royalsociety.org.nz gateway to science and technology in new zealand the royal society of new zealand has operated

More information

Corporate slide master

Corporate slide master Corporate slide master Recommendations on Health & Wealth in Wales Ifan Evans Deputy Director Healthcare Innovation Welsh Government 1 What are these recommendations for? The Board s purpose is to: assist

More information

Medicines Manufacturing in the UK 2017

Medicines Manufacturing in the UK 2017 Medicines Manufacturing in the UK 2017 Moderator: Magda Papadaki, PhD Head of Manufacturing Innovation The Association of the British Pharmaceutical Industry Medicines Manufacturing Industry Partnership

More information

HDR UK & Digital Innovation Hubs Introduction. 22 nd November 2018

HDR UK & Digital Innovation Hubs Introduction. 22 nd November 2018 HDR UK & Digital Innovation Hubs Introduction 22 nd November 2018 Health Data Research UK s vision To create a thriving, high-energy UK-wide network of inter-disciplinary research expertise that will:

More information

Human factors and design in future health care

Human factors and design in future health care Human factors and design in future health care Peter Buckle 1, Simon Walne 1, Simone Borsci 1,2 and Janet Anderson 3 1. NIHR London In Vitro Diagnostics Co-operative, Division of Surgery, Department of

More information

Security and Risk Assessment in GDPR: from policy to implementation

Security and Risk Assessment in GDPR: from policy to implementation Global Data Privacy Security and Risk Assessment in GDPR: from policy to implementation Enisa Workshop Roma - February 8, 2018 Nicola Orlandi Head of Data Privacy Pharma Nicola Orlandi Nicola Orlandi is

More information

Technology and Innovation in the NHS Scottish Health Innovations Ltd

Technology and Innovation in the NHS Scottish Health Innovations Ltd Technology and Innovation in the NHS Scottish Health Innovations Ltd Introduction Scottish Health Innovations Ltd (SHIL) has, since 2002, worked in partnership with NHS Scotland to identify, protect, develop

More information

Where the brightest scientific minds thrive. IMED Early Talent and Post Doc programmes

Where the brightest scientific minds thrive. IMED Early Talent and Post Doc programmes Where the brightest scientific minds thrive. IMED Early Talent and Post Doc programmes Scientific innovation is at the heart of everything we do. Scientific innovation is at the heart of our business and

More information

A Science & Innovation Audit for the West Midlands

A Science & Innovation Audit for the West Midlands A Science & Innovation Audit for the West Midlands June 2017 Summary Report Key Findings and Moving Forward 1. Key findings and moving forward 1.1 As the single largest functional economic area in England

More information

Written Submission for the Pre-Budget Consultations in Advance of the 2019 Budget By: The Danish Life Sciences Forum

Written Submission for the Pre-Budget Consultations in Advance of the 2019 Budget By: The Danish Life Sciences Forum Written Submission for the Pre-Budget Consultations in Advance of the 2019 Budget By: The Danish Life Sciences Forum List of recommendations: Recommendation 1: That the government creates a Life Sciences

More information

THE NUMBERS OPENING SEPTEMBER BE PART OF IT

THE NUMBERS OPENING SEPTEMBER BE PART OF IT THE NUMBERS 13million new development dedicated to STEM for Plymouth 5.43million funding from the Heart of the South West Local Enterprise Partnership s Growth Deal 2.7million from the Regional Growth

More information

Enfield CCG. CCG 360 o stakeholder survey 2015 Main report. Version 1 Internal Use Only Version 1 Internal Use Only

Enfield CCG. CCG 360 o stakeholder survey 2015 Main report. Version 1 Internal Use Only Version 1 Internal Use Only CCG 360 o stakeholder survey 2015 Main report Version 1 Internal Use Only 1 Table of contents Slide 3 Background and objectives Slide 4 Methodology and technical details Slide 6 Interpreting the results

More information

Oxfordshire CCG. CCG 360 o stakeholder survey 2015 Main report. Version 1 Internal Use Only Version 1 Internal Use Only

Oxfordshire CCG. CCG 360 o stakeholder survey 2015 Main report. Version 1 Internal Use Only Version 1 Internal Use Only CCG 360 o stakeholder survey 2015 Main report Version 1 Internal Use Only 1 Table of contents Slide 3 Background and objectives Slide 4 Methodology and technical details Slide 6 Interpreting the results

More information

Southern Derbyshire CCG. CCG 360 o stakeholder survey 2015 Main report. Version 1 Internal Use Only Version 1 Internal Use Only

Southern Derbyshire CCG. CCG 360 o stakeholder survey 2015 Main report. Version 1 Internal Use Only Version 1 Internal Use Only CCG 360 o stakeholder survey 2015 Main report Version 1 Internal Use Only 1 Table of contents Slide 3 Background and objectives Slide 4 Methodology and technical details Slide 6 Interpreting the results

More information

South Devon and Torbay CCG. CCG 360 o stakeholder survey 2015 Main report Version 1 Internal Use Only

South Devon and Torbay CCG. CCG 360 o stakeholder survey 2015 Main report Version 1 Internal Use Only CCG 360 o stakeholder survey 2015 Main report 1 Table of contents Slide 3 Background and objectives Slide 4 Methodology and technical details Slide 6 Interpreting the results Slide 7 Using the results

More information

CCG 360 o stakeholder survey 2017/18

CCG 360 o stakeholder survey 2017/18 CCG 360 o stakeholder survey 2017/18 Case studies of high performing and improved CCGs 1 Contents 1 Background and key themes 2 3 4 5 6 East and North Hertfordshire CCG: Building on a strong internal foundation

More information

Portsmouth CCG. CCG 360 o stakeholder survey 2015 Main report. Version 1 Internal Use Only Version 1 Internal Use Only

Portsmouth CCG. CCG 360 o stakeholder survey 2015 Main report. Version 1 Internal Use Only Version 1 Internal Use Only CCG 360 o stakeholder survey 2015 Main report Version 1 Internal Use Only 1 Table of contents Slide 3 Background and objectives Slide 4 Methodology and technical details Slide 6 Interpreting the results

More information

Collaboration Agreement

Collaboration Agreement Collaboration Agreement Central London, West London, Hammersmith & Fulham, Hounslow, Ealing Clinical Commissioning Groups January 2014 Version 5 1 Context In December 2011 the eight North West London (NWL)

More information

MedTech Europe position on future EU cooperation on Health Technology Assessment (21 March 2017)

MedTech Europe position on future EU cooperation on Health Technology Assessment (21 March 2017) MedTech Europe position on future EU cooperation on Health Technology Assessment (21 March 2017) Table of Contents Executive Summary...3 The need for healthcare reform...4 The medical technology industry

More information

Sutton CCG. CCG 360 o stakeholder survey 2015 Main report. Version 1 Internal Use Only Version 1 Internal Use Only

Sutton CCG. CCG 360 o stakeholder survey 2015 Main report. Version 1 Internal Use Only Version 1 Internal Use Only CCG 360 o stakeholder survey 2015 Main report Version 1 Internal Use Only 1 Table of contents Slide 3 Background and objectives Slide 4 Methodology and technical details Slide 6 Interpreting the results

More information

Diffusion of Innovations Theory. 2 nd National Medicine Reconciliation Workshop - 6 September 2011

Diffusion of Innovations Theory. 2 nd National Medicine Reconciliation Workshop - 6 September 2011 Diffusion of Innovations Theory 2 nd National Medicine Reconciliation Workshop - 6 September 2011 Diffusion of Innovations (definition) Spread of messages that are perceived as new ideas the process by

More information

Health & Social Care Industrial Innovation

Health & Social Care Industrial Innovation Health & Social Care Industrial Innovation Mr Andrew Fowlie Scottish Government Health Innovations Team SHINE North Sea Region Program 2014 2020 Scotland s Medical Technologies Landscape Imaging Non Imaging

More information

A manifesto for global sustainable health. Sustainable Health Symposium Cambridge, UK 25th July 2017

A manifesto for global sustainable health. Sustainable Health Symposium Cambridge, UK 25th July 2017 A manifesto for global sustainable health Sustainable Health Symposium Cambridge, UK 25th July 2017 Introduction Across the globe, the health of individuals, their communities and the planet is in crisis

More information

Draft Plan of Action Chair's Text Status 3 May 2008

Draft Plan of Action Chair's Text Status 3 May 2008 Draft Plan of Action Chair's Text Status 3 May 2008 Explanation by the Chair of the Drafting Group on the Plan of Action of the 'Stakeholder' Column in the attached table Discussed Text - White background

More information

Data-Driven Evaluation: The Key to Developing Successful Pharma Partnerships

Data-Driven Evaluation: The Key to Developing Successful Pharma Partnerships R&D Solutions for PHARMA & LIFE SCIENCES DRUG DISCOVERY & DEVELOPMENT Data-Driven Evaluation: The Key to Developing Successful Pharma Partnerships Summary For pharmaceutical companies to succeed, it is

More information

3. Title NHSE & Ipsos Mori CCG 360 Stakeholder Survey

3. Title NHSE & Ipsos Mori CCG 360 Stakeholder Survey 1. Record Type? 2. Unique Number Reassessment R00423 3. Title NHSE & Ipsos Mori CCG 360 Stakeholder Survey 4. Collection Type National 5. Other Reference 6. Description CCGs need to have strong relationships

More information

Doing, supporting and using public health research. The Public Health England strategy for research, development and innovation

Doing, supporting and using public health research. The Public Health England strategy for research, development and innovation Doing, supporting and using public health research The Public Health England strategy for research, development and innovation Draft - for consultation only About Public Health England Public Health England

More information

FDA Centers of Excellence in Regulatory and Information Sciences

FDA Centers of Excellence in Regulatory and Information Sciences FDA Centers of Excellence in Regulatory and Information Sciences February 26, 2010 Dale Nordenberg, MD novasano HEALTH AND SCIEN Discussion Topics Drivers for evolution in regulatory science Trends in

More information

Technology transfer options for low-carbon development

Technology transfer options for low-carbon development Technology transfer options for low-carbon development Mongi Hamdi Head, Science, Technology and ICT Branch UNCTAD and Head of the CSTD Secretariat UNDP Conference Climate Change and the Road to Rio Algiers,

More information

IFT STRATEGIC PLAN. 2017/18 Strategic Objectives

IFT STRATEGIC PLAN. 2017/18 Strategic Objectives IFT STRATEGIC PLAN 2017/18 Strategic Objectives STRATEGIC STRUCTURE Feeding Tomorrow Mission IFT Mission IFTSA Mission Strategic Priorities Vision Vision Vision Core Values Strategic Objectives VISION

More information

We are embarking on a new and exciting phase of dance development in the North West. This is where we get to dream big.

We are embarking on a new and exciting phase of dance development in the North West. This is where we get to dream big. Ambition We are embarking on a new and exciting phase of dance development in the North West. This is where we get to dream big. Who are we? We are anyone involved or connected to dance in the North West

More information

Health Innovation Manchester

Health Innovation Manchester Health Innovation Manchester Accelerating innovation Discover Develop Deploy Our vision is to be a recognised international leader in accelerating innovation that transforms citizens health and wellbeing

More information

[Definitions of terms that are underlined are found at the end of this document.]

[Definitions of terms that are underlined are found at the end of this document.] Policy Direction - Pharmaceutical Industry Relationships [Definitions of terms that are underlined are found at the end of this document.] Rationale and Relationship to Mission, Principles and Values The

More information

Catapult Network. Launching your ideas with the UK s new centres for innovation

Catapult Network. Launching your ideas with the UK s new centres for innovation Catapult Network Launching your ideas with the UK s new centres for innovation The vision What is a Catapult? Hundreds of thousands of businesses in the UK are hungry for growth and capable of bringing

More information

Enfield CCG. CCG 360 o stakeholder survey 2014 Summary report. Version 1 Internal Use Only Version 1 Internal Use Only

Enfield CCG. CCG 360 o stakeholder survey 2014 Summary report. Version 1 Internal Use Only Version 1 Internal Use Only CCG 360 o stakeholder survey 2014 Summary report Version 1 Internal Use Only 1 Background and objectives Clinical Commissioning Groups (CCGs) need to have strong relationships with a range of Clinical

More information

Sutton CCG. CCG 360 o stakeholder survey 2014 Summary report. Version 1 Internal Use Only Version 1 Internal Use Only

Sutton CCG. CCG 360 o stakeholder survey 2014 Summary report. Version 1 Internal Use Only Version 1 Internal Use Only CCG 36 o stakeholder survey 214 Summary report Version 1 Internal Use Only 13-98464-1 Version 1 Internal Use Only 1 Background and objectives Clinical Commissioning Groups (CCGs) need to have strong relationships

More information

Growing the national institute for data science and artificial intelligence

Growing the national institute for data science and artificial intelligence Growing the national institute for data science and artificial intelligence There has never been a more significant time to work in data science and AI. There is recognition of the importance of these

More information

Technology and Innovation in the NHS Highlands and Islands Enterprise

Technology and Innovation in the NHS Highlands and Islands Enterprise Technology and Innovation in the NHS Highlands and Islands Enterprise Introduction Highlands and Islands Enterprise (HIE) welcomes the opportunity to respond to the Committee s call for views. We recognise

More information

Board of Directors Non Executive Directors

Board of Directors Non Executive Directors Board of Directors Non Executive Directors Beatrice Fraenkel Chairman Appointed 1 December 2008, Beatrice s terms ends 3 November 2019. Beatrice is an ergonomist and industrial designer. She is Director

More information

Smart Management for Smart Cities. How to induce strategy building and implementation

Smart Management for Smart Cities. How to induce strategy building and implementation Smart Management for Smart Cities How to induce strategy building and implementation Why a smart city strategy? Today cities evolve faster than ever before and allthough each city has a unique setting,

More information

Medical Education Activities

Medical Education Activities Medical Education Activities Author: Marie-Claire PICKAERT EFPIA Deputy Director General BioMed Alliance Brussels, 9 November 2016 MCP 07-11--2016 Declaration of Interest Marie-Claire Pickaert is a full-time

More information

SAFEGUARDING ADULTS FRAMEWORK. Prevention and effective responses to neglect, harm and abuse is a basic requirement of modern health care services.

SAFEGUARDING ADULTS FRAMEWORK. Prevention and effective responses to neglect, harm and abuse is a basic requirement of modern health care services. SAFEGUARDING ADULTS FRAMEWORK Introduction Prevention and effective responses to neglect, harm and abuse is a basic requirement of modern health care services. Safeguarding adults involves a range of additional

More information

Centre for Healthcare Technologies

Centre for Healthcare Technologies Centre for Healthcare Technologies Steve Morgan www.healthcaretechnologies.ac.uk Launched 29.2.16 The future: doom and gloom? 2011 2015 Healthcare Public Patients Clinicians Policy RCUK Regulators NHS

More information

The case for quality

The case for quality The case for quality Around the world, up to two billion people lack access to quality essential medicines. Poor-quality medicines undermine the treatment of some of the world s most pressing diseases,

More information

Accountable Officer Report

Accountable Officer Report Accountable Officer Report 1. CCG Annual Report and Annual Public Meeting At its 24 May 2018 meeting, in line with delegated responsibilities, the Audit and Governance Committee approved the CCG s Annual

More information

RESEARCH AND INNOVATION STRATEGY

RESEARCH AND INNOVATION STRATEGY RESEARCH AND INNOVATION STRATEGY 2015 2020 WELCOME Delivering new opportunities through globally significant research and innovation excellence The Research and Innovation Strategy is the result of significant

More information

Quality by Design, Clinical Relevance & Lifecycle Considerations

Quality by Design, Clinical Relevance & Lifecycle Considerations Quality by Design, Clinical Relevance & Lifecycle Considerations Robert Iser Acting Director Office of Process & Facilities / OPQ / CDER IFPAC 2016 1 FDA Quality Related Guidance and Initiatives Initiatives

More information

West Norfolk CCG. CCG 360 o stakeholder survey 2014 Main report. Version 1 Internal Use Only Version 7 Internal Use Only

West Norfolk CCG. CCG 360 o stakeholder survey 2014 Main report. Version 1 Internal Use Only Version 7 Internal Use Only CCG 360 o stakeholder survey 2014 Main report Version 1 Internal Use Only 1 Background and objectives Clinical Commissioning Groups (CCGs) need to have strong relationships with a range of health and care

More information

IAPT What Now? What Next? Kevin Mullins Head of Mental Health 2 nd October 2015

IAPT What Now? What Next? Kevin Mullins Head of Mental Health 2 nd October 2015 IAPT What Now? What Next? Kevin Mullins Head of Mental Health 2 nd October 2015 Clinical Networks Business Planning Parameters for 2015/16 Business Planning Parameters for 2015/16 1. There should be a

More information

Kernow CCG CCG 360 o Stakeholder Survey

Kernow CCG CCG 360 o Stakeholder Survey CCG 360 o Stakeholder Survey 2017-18 Findings 1 Table of contents Slide 3 Summary Slide 6 Introduction Slide 7 Background and objectives Slide 8 Methodology and technical details Slide 10 Interpreting

More information

Authors Heidi Gautschi Alexandre Raynaud Damien Vossion Michael Wade. Digital Patient Engagement. Insights for the Pharmaceutical Industry

Authors Heidi Gautschi Alexandre Raynaud Damien Vossion Michael Wade. Digital Patient Engagement. Insights for the Pharmaceutical Industry Authors Heidi Gautschi Alexandre Raynaud Damien Vossion Michael Wade Digital Patient Engagement Insights for the Pharmaceutical Industry March 2018 2 DIGITAL PATIENT ENGAGEMENT: INSIGHTS FOR THE PHARMACEUTICAL

More information

The Royal College of Radiologists Response to: House of Lords Select Committee on Artificial Intelligence 6 September 2017

The Royal College of Radiologists Response to: House of Lords Select Committee on Artificial Intelligence 6 September 2017 Introduction The Royal College of Radiologists Response to: House of Lords Select Committee on Artificial Intelligence 6 September 2017 1. The Royal College of Radiologists (RCR) works with our 10,000

More information

2. Evidence themes and their importance along the development path

2. Evidence themes and their importance along the development path 1. The issue On 12 th July 2017, MedCity, Digital Health.London and BSI hosted a Digital Health Technology and Evidence Stakeholder workshop. It brought together the key experts for the innovation development

More information

Innovation & Knowledge management

Innovation & Knowledge management Innovation & Knowledge management Lotte Jaspers, Yellow Research 1 My Background From University/medical TTO to start-up to setting up my own company 3 pillar career from Expert to Manager to Expert IPR

More information

Vetter. The experts in complex development, aseptic manufacturing and packaging. Facts figures data 2018

Vetter. The experts in complex development, aseptic manufacturing and packaging. Facts figures data 2018 Vetter The experts in complex development, aseptic manufacturing and packaging Facts figures data 2018 This is Vetter Founded *50 Sales 2017 Our portfolio Vetter is an international pharmaceutical service

More information

A review of the role and costs of clinical commissioning groups

A review of the role and costs of clinical commissioning groups A picture of the National Audit Office logo Report by the Comptroller and Auditor General NHS England A review of the role and costs of clinical commissioning groups HC 1783 SESSION 2017 2019 18 DECEMBER

More information

Led by clinicians, accountable to local people. East Lancashire Clinical Commissioning Group: Equality & Inclusion Annual Report

Led by clinicians, accountable to local people. East Lancashire Clinical Commissioning Group: Equality & Inclusion Annual Report Clinical Commissioning Group: Equality & Inclusion Annual Report Foreword 3 Introduction and Aims of the Report 4 Commissioning Intentions 4 Our Population 5 Compliance with the Public Sector Equality

More information

A Focus on Health Data Infrastructure, Capacity and Application of Outcomes Data

A Focus on Health Data Infrastructure, Capacity and Application of Outcomes Data External Review of Pan-Canadian Health Organizations Thank you for the opportunity to provide input for your ongoing review of the Pan- Canadian Health Organizations (PCHOs). This submission is made on

More information

Imagine your future lab. Designed using Virtual Reality and Computer Simulation

Imagine your future lab. Designed using Virtual Reality and Computer Simulation Imagine your future lab Designed using Virtual Reality and Computer Simulation Bio At Roche Healthcare Consulting our talented professionals are committed to optimising patient care. Our diverse range

More information

Parenteral Nutrition Down Under Inc. (PNDU) Working with Pharmaceutical Companies Policy (Policy)

Parenteral Nutrition Down Under Inc. (PNDU) Working with Pharmaceutical Companies Policy (Policy) Parenteral Nutrition Down Under Inc. (PNDU) Working with Pharmaceutical Companies Policy (Policy) BACKGROUND (Reason or Purpose) The purpose of this Policy is to provide clear principles and guidance about

More information

WorldSkills UK Construction Roundtable Report: The future of construction is manufacturing June 2018

WorldSkills UK Construction Roundtable Report: The future of construction is manufacturing June 2018 WorldSkills UK Construction Roundtable Report: The future of construction is manufacturing June 2018 Introduction This roundtable event was conceived out of a need to develop a future-facing perspective

More information

The Future of Patient Data The Global View Key Insights Berlin 18 April The world s leading open foresight program

The Future of Patient Data The Global View Key Insights Berlin 18 April The world s leading open foresight program The Future of Patient Data The Global View Key Insights Berlin 18 April 2018 The world s leading open foresight program Context Over a 6 month period, 12 expert discussions have taken place around the

More information

Intellectual Property

Intellectual Property Intellectual Property Johnson & Johnson believes that the protection of intellectual property (IP) is essential to rewarding innovation and promoting medical advances. We are committed: to raising awareness

More information

June 12, 2017 Health and the Social Innovation Ecosystem

June 12, 2017 Health and the Social Innovation Ecosystem Waterloo Region June 12, 2017 Health and the Social Innovation Ecosystem Why work on a wellbeing initiative? Community challenges are increasingly complex and therefore need multi-stakeholder approaches.

More information

CCG Improvement and Assessment Framework 2016/17. Briefing Document

CCG Improvement and Assessment Framework 2016/17. Briefing Document CCG Improvement and Assessment Framework 2016/17 Briefing Document 4 th April 2016 Executive Summary NHS England has launched a new Improvement and Assessment Framework for Clinical Commissioning Groups

More information

A Roadmap For Building Indigenous Digital Excellence: Looking To 2030

A Roadmap For Building Indigenous Digital Excellence: Looking To 2030 A Roadmap For Building Indigenous Digital Excellence: Looking To 2030 T: +612 9046 7855 E: info@ncie.org.au idx.org.au Facebook: IndigenousDigitalExcellence Twitter: IndigenousDX 180 George Street Redfern

More information

Parkinson s World A transformational project by The Cure Parkinson s Trust

Parkinson s World A transformational project by The Cure Parkinson s Trust Parkinson s World A transformational project by The Cure Parkinson s Trust Executive Summary During my time working in the Parkinson s field, I have come to realise there is a patent lack of communication

More information

Before I talk through the strategy itself, I want to tell you more about why

Before I talk through the strategy itself, I want to tell you more about why This presentation was given by Dr Annette Bramley, the Healthcare Technologies Theme leader. She thanked Professor Nelson and Professor Taylor for their presentations, and thanked everyone at the meeting

More information

Diversity in Science Technology Engineering and Maths (STEM)

Diversity in Science Technology Engineering and Maths (STEM) 1 Diversity in Science Technology Engineering and Maths (STEM) Summary Aim to support UK secure maximum economic and social benefits from its world class research base by increasing STEM skills and diversity

More information

About the awards. Categories. Knowledge Transfer Initiative of the Year Knowledge Transfer Achiever of the Year. Judging panel

About the awards. Categories. Knowledge Transfer Initiative of the Year Knowledge Transfer Achiever of the Year. Judging panel 2015 The KTI Impact Awards recognise successful commercialisation of Irish State-funded research that translates knowledge and expertise for the wider benefit of our economy and society. The awards also

More information

NEWS RELEASE. Life sciences companies tout their expertise in India

NEWS RELEASE. Life sciences companies tout their expertise in India For Immediate Release 2014MIT0016-000196 Feb. 19, 2014 NEWS RELEASE International Trade and Responsible for the Asia Pacific Strategy and Multiculturalism Life sciences companies tout their expertise in

More information

Scottish Health and Life Sciences Innovation Workshop. The Industrial Strategy Challenge Fund

Scottish Health and Life Sciences Innovation Workshop. The Industrial Strategy Challenge Fund Scottish Health and Life Sciences Innovation Workshop The Industrial Strategy Challenge Fund Ian Campbell Innovate UK, Director of Health &Life Sciences Email:Ian.Campbell@innovateuk.gov.uk Twitter: @IanWCampbell

More information

Triennial Review of the Medicines and Healthcare Products Regulatory Agency. Call for Evidence

Triennial Review of the Medicines and Healthcare Products Regulatory Agency. Call for Evidence Triennial Review of the Medicines and Healthcare Products Regulatory Agency Call for Evidence Title: Triennial Review of the Medicines and Healthcare Products Regulatory Agency Call for Evidence Author:

More information

Supporting Innovation through Regulation and Science

Supporting Innovation through Regulation and Science Supporting Innovation through Regulation and Science Larry O Dwyer, Scientific Affairs Manager PEARRL Regulatory Science Symposium 21 st June 2017, School of Pharmacy, UCC Overview of Presentation Drivers

More information

NIHR / Wellcome Trust King s Clinical Research Facility. Guidance for Investigators

NIHR / Wellcome Trust King s Clinical Research Facility. Guidance for Investigators NIHR / Wellcome Trust King s Clinical Research Facility Guidance for Investigators Introduction The NIHR Clinical Research Facilities provide dedicated facilities to support the delivery of externally-funded

More information

Eastern Cheshire CCG CCG 360 o Stakeholder Survey

Eastern Cheshire CCG CCG 360 o Stakeholder Survey CCG 360 o Stakeholder Survey 2017-18 Findings 1 Table of contents Slide 3 Summary Slide 6 Introduction Slide 7 Background and objectives Slide 8 Methodology and technical details Slide 10 Interpreting

More information

EU s Innovative Medical Technology and EMA s Measures

EU s Innovative Medical Technology and EMA s Measures EU s Innovative Medical Technology and EMA s Measures 27 October 2017 Summit symposium 25-27 October 2017, Kyoto, Japan Presented by Guido Rasi Executive Director, European Medicines Agency (EMA) An agency

More information

WHY FORM THE HEALTH CARE TEACHING COUNTY PARTNERSHIP?

WHY FORM THE HEALTH CARE TEACHING COUNTY PARTNERSHIP? WHY FORM THE HEALTH CARE TEACHING COUNTY PARTNERSHIP? Insanity: Doing the same thing over and over again and expecting different results. - Albert Einstein When you come to a fork in the road, take it.

More information

Mining Innovation: The Importance of Science Entreprise

Mining Innovation: The Importance of Science Entreprise 1 Mining Innovation: The Importance of Science Entreprise Donna Kirkwood, Ph.D, Geo Deputy Chief Scientist Natural Resources Canada Prepared for the Mining Diesel Emissions Council Conference Toronto October

More information

25 th Workshop of the EURORDIS Round Table of Companies (ERTC)

25 th Workshop of the EURORDIS Round Table of Companies (ERTC) 25 th Workshop of the EURORDIS Round Table of Companies (ERTC) Healthcare Companies & European Reference Networks: Expectations & Potential for Collaboration Introduction Tuesday 26 September, 2017 (09:00

More information

Digital Health and Introducing Innovative Technologies in the NHS

Digital Health and Introducing Innovative Technologies in the NHS Digital Health and Introducing Innovative Technologies in the NHS 22 September 2015 NATIONAL INFORMATION BOARD techuk.org @techuk #techuk Digital Health and introducing innovative technologies in the NHS

More information

How Paediatric Research Networks can help drug development

How Paediatric Research Networks can help drug development How Paediatric Research Networks can help drug development Mark Turner An agency of the European Union Why networks? Significant increase in trials and participants Delays are now significant Networks

More information

Advancing Health and Prosperity. A Brief to the Advisory Panel on Healthcare Innovation

Advancing Health and Prosperity. A Brief to the Advisory Panel on Healthcare Innovation Advancing Health and Prosperity A Brief to the Advisory Panel on Healthcare Innovation November 2014 About ITAC ITAC is the voice of the Canadian information and communications technologies (ICT) industry

More information

NHS England CCG Authorisation

NHS England CCG Authorisation NHS England CCG Authorisation Post Authorisation December 2013 Review Conditions Report CCG name: Vale of York CCG Wave: 3 Regional Operations Director Jon Develing Date report generated: 22/01/2014 Vale

More information

INTRODUCTION OUR VISION: We are driven to be a preeminent college of pharmacy in the world. Our world begins in Iowa. OUR MISSION:

INTRODUCTION OUR VISION: We are driven to be a preeminent college of pharmacy in the world. Our world begins in Iowa. OUR MISSION: BRAND GUIDE INTRODUCTION TABLE OF CONTENTS BRAND MESSAGING Introduction.... 1 Core Brand Values... 2 BRAND IDENTITY Logo Usage.... 6 Primary Logo Variations.... 7 Department & Division Logos.... 8 What

More information

Foreword. Simon Hunt Managing Director Oxford Policy Management

Foreword. Simon Hunt Managing Director Oxford Policy Management UK Gender Pay Gap Report 2017-2018 Foreword Equality and inclusivity are at the heart of what we do both in fulfilling our mission and how we act as an employer. We strive to provide an equal platform

More information

DR ANDREA PAVLICKOVA EUROPEAN SERVICE DEVELOPMENT MANAGER NHS 24, SCOTLAND

DR ANDREA PAVLICKOVA EUROPEAN SERVICE DEVELOPMENT MANAGER NHS 24, SCOTLAND DR ANDREA PAVLICKOVA EUROPEAN SERVICE DEVELOPMENT MANAGER NHS 24, SCOTLAND EUPHA CONFERENCE, VIENNA 10-12 NOVEMBER 16 @ SCIROCCO_EU 1 SCIROCCO Project EU Health Programme (CHAFEA) EC funding: 1,322, 775

More information

TECHNOLOGY ENABLED CARE Supporting Service Transformation Delivery Plan 2018/19

TECHNOLOGY ENABLED CARE Supporting Service Transformation Delivery Plan 2018/19 TECHNOLOGY ENABLED CARE Supporting Service Transformation Delivery Plan 2018/19 April 2018 Introduction 1. The TEC Board agreed four Strategic Priorities in August 2017 for furthering the development and

More information